Quantitative Proteomics Analysis of Tissue Interstitial Fluid for Identification of Novel Serum Candidate Diagnostic Marker for Hepatocellular Carcinoma.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 27216119)

Published in Sci Rep on May 24, 2016

Authors

Wei Sun1, Baocai Xing2, Lihai Guo3, Zhilei Liu1,4, Jinsong Mu5, Longqin Sun1, Handong Wei1, Xiaohang Zhao6, Xiaohong Qian1, Ying Jiang1, Fuchu He1,7

Author Affiliations

1: State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences Beijing, Beijing Institute of Radiation Medicine, Beijing 102206, China.
2: Beijing Cancer Hospital, Beijing 100036, China.
3: AB SCIEX, Beijing 100015, China.
4: MOE Key Laboratory of Bioinformatics, School of Life Sciences, Tsinghua University, Beijing 100084, China.
5: 302 Hospital of PLA, Beijing 100039, China.
6: State Key Laboratory of Molecular Oncology, Cancer Institute &Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Beijing 100021, China.
7: Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China.

Articles cited by this

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology (2007) 26.78

Hepatitis B virus infection. N Engl J Med (1997) 14.50

Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol (2006) 10.14

Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol (2001) 4.46

Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma. J Hepatol (2013) 1.80

Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells. Hepatology (2010) 1.69

Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery. Mol Cell Proteomics (2004) 1.57

S100 proteins in cancer. Nat Rev Cancer (2015) 1.35

S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis. Hepatology (2009) 1.28

High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection. Hum Pathol (2008) 1.26

Hepatocellular carcinoma: epidemiology and clinical aspects. Mol Aspects Med (2007) 1.14

Proteomic profiling of heat shock protein 70 family members as biomarkers for hepatitis C virus-related hepatocellular carcinoma. Proteomics (2003) 1.07

Overexpression of high-mobility group box 2 is associated with tumor aggressiveness and prognosis of hepatocellular carcinoma. Clin Cancer Res (2010) 1.04

Immunohistochemical investigation of migration inhibitory factor-related protein (MRP)-14 expression in hepatocellular carcinoma. Med Oncol (2000) 0.98

Quantitative proteomics analysis of early recurrence/metastasis of huge hepatocellular carcinoma following radical resection. Proteome Sci (2014) 0.92

Hepatocellular carcinomas show abnormal expression of fibronectin protein. Mod Pathol (2002) 0.91

Characterization of the liver tissue interstitial fluid (TIF) proteome indicates potential for application in liver disease biomarker discovery. J Proteome Res (2010) 0.87

Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma. Int J Oncol (2009) 0.87

S100P expression is a novel prognostic factor in hepatocellular carcinoma and predicts survival in patients with high tumor stage or early recurrent tumors. PLoS One (2013) 0.86

NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma. Nat Commun (2015) 0.85

A pro-tumorigenic function of S100A8/A9 in carcinogen-induced hepatocellular carcinoma. Cancer Lett (2015) 0.84

Identification of proteins differentially expressed between capillary endothelial cells of hepatocellular carcinoma and normal liver in an orthotopic rat tumor model using 2-D DIGE. Proteomics (2010) 0.84

S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK pathways. Exp Cell Res (2015) 0.84

Expression of aldo-keto reductase family 1 member b10 in the early stages of human hepatocarcinogenesis. Int J Mol Sci (2014) 0.84

Immunology of hepatocellular carcinoma. World J Hepatol (2015) 0.83

A novel prognostic factor for hepatocellular carcinoma: protein disulfide isomerase. Korean J Intern Med (2014) 0.83

Conditioning solid tumor microenvironment through inflammatory chemokines and S100 family proteins. Cancer Lett (2015) 0.79

Ephrin-A1 expression induced by S100A8 is mediated by the toll-like receptor 4. Biochem Biophys Res Commun (2013) 0.78

Quantitative Proteomics Reveals Membrane Protein-Mediated Hypersaline Sensitivity and Adaptation in Halophilic Nocardiopsis xinjiangensis. J Proteome Res (2015) 0.77